Some links in this article are partner links. If you sign up through one, we may earn a commission at no cost to you. It never changes which panels we recommend or what we say about them.
If you have ever searched for how much clinical trials pay, you have probably seen everything from "$50" to "over $10,000" — sometimes on the same page. Both numbers are real. They just describe completely different kinds of studies.
We connect people with paid research studies every day, so we will give you the honest version: realistic compensation ranges by study type, why the numbers vary so widely, and the caveats most articles skip — starting with the biggest one. Clinical trials carry real medical risk. Investigational treatments can cause side effects, some of them serious, and no stipend changes that. The money should never be the reason you accept a medical risk you would otherwise decline.
One more thing to be clear about up front: trial compensation is a stipend for your time, travel, and inconvenience. It is not a wage, and it is not "payment for taking a drug." Ethical research compensates you because participating costs you something — hours, commutes, sometimes weeks living at a clinic — not because you are selling access to your body.
With that framing in place, here are the numbers.
See which trials you may qualify for →
The short answer: typical ranges by study type
Compensation varies enormously, but most paid studies fall into one of three buckets:
| Study type | Common total compensation | Typical commitment |
|---|---|---|
| Observational studies and registries | Roughly $25–$200 | Surveys, records access, occasional visit or sample |
| Outpatient clinical trials (Phases 2–4) | Roughly $50–$400 per visit; $500–$2,000+ total | Multiple clinic visits over weeks or months |
| Phase 1 inpatient studies | Roughly $150–$300 per overnight day; $2,000–$7,000+ total | Days to weeks living at a research clinic |
The longest multi-week inpatient studies can pay more than $10,000 — and they are also the most demanding and most selective studies on the list. None of these figures is guaranteed; every study sets its own compensation, and payouts vary by sponsor, location, and design.
If you are new to paid research entirely, our clinical trials guides cover the basics from the ground up.
Why the ranges are so wide
Four factors drive almost all of the variation in trial pay:
1. Duration. A study with three visits over two weeks pays less than one with fifteen visits over six months. More of your time, more compensation.
2. Inpatient vs. outpatient. Inpatient (or "confinement") studies require you to live at the research facility — controlled meals, scheduled blood draws, no coming and going. That is the single biggest pay multiplier, because it asks the most of you.
3. Procedures. A study built around questionnaires and a cheek swab pays less than one involving frequent blood draws, imaging, or overnight monitoring. More invasive or more frequent procedures generally mean a higher stipend.
4. Travel and burden. Long drives to the site, fasting requirements, food and caffeine restrictions, daily symptom diaries — the more a study disrupts normal life, the more it typically compensates.
There is also a ceiling you should know about. Every legitimate trial's compensation is reviewed by an independent ethics board (an IRB), which checks that payment is fair for the burden involved but not so large that it pressures people into risks they would otherwise refuse. That review is part of why real studies pay in ranges — not the inflated lottery numbers you sometimes see in ads.
What each study type really pays — and really asks
Phase 1 inpatient studies: the highest stipends, the biggest asks
Phase 1 studies are early-stage safety studies, and many enroll healthy volunteers rather than patients. The classic format is a residential stay: you check into the research clinic, live there for several days to several weeks, eat controlled meals, and have blood drawn on a tight schedule.
Because that is a genuine disruption to your life, these studies commonly compensate roughly $150–$300 per overnight day, with totals for longer studies commonly landing between $2,000 and $7,000, and occasionally higher.
Two honest counterweights. First, Phase 1 studies involve treatments whose effects in humans are the least characterized — that is precisely what the study exists to learn. Second, screening is strict: for a given Phase 1 study, many or most applicants are screened out on labs, health history, medications, or lifestyle factors. High-paying confinement studies are not a spigot you can turn on at will.
Outpatient trials (Phases 2–4): moderate pay, spread over time
These trials enroll people who have the condition being studied. You live at home and come in for scheduled visits — often somewhere between a handful and a dozen or more over several months.
Per-visit stipends commonly run roughly $50–$400 depending on what the visit involves, and full-study totals commonly land between $500 and $2,000 or more. Many trials also provide study-related care and the investigational treatment at no cost — a real benefit for some participants, but it is care, not compensation, and we would never suggest joining a trial primarily to access treatment. That is a conversation for you and your doctor.
Observational studies and registries: lowest burden, lowest pay
Some paid research involves no experimental treatment at all — researchers follow your health over time through surveys, medical records, or occasional samples. Compensation is modest, commonly $25–$200 total, but so is the ask.
One more line item worth knowing: many sites compensate you for the screening visit itself, often in the range of $25–$100, even if you do not qualify for the study.
Illustrative breakdown: what a "$3,000 study" actually requires
This is a hypothetical example built from typical study structures — not a real person's account.
- 14-night inpatient confinement at roughly $200 per night: about $2,800
- Three outpatient follow-up visits at roughly $65 each: about $200
- Total: roughly $3,000, typically paid in installments as you complete each stage
What that $3,000 would actually cost you: passing a strict screening that most applicants fail, two full weeks living inside a research clinic, daily blood draws, controlled meals, restrictions on caffeine and alcohol, and time away from work and family. It is real money for real inconvenience — not passive income. We walk through the fuller math in what a $3,000 month really looks like.
How and when you actually get paid
Legitimate studies pay on a prorated schedule — per visit or per completed stage — rather than holding everything until the end. FDA guidance to research sites says payment should accrue as you participate, so leaving a study early does not mean forfeiting what you have already earned. A modest completion bonus is common and acceptable; "all or nothing" payment is a red flag.
Payment usually arrives by reloadable debit card, check, or direct deposit. Stipends are generally taxable income, and sites commonly issue tax paperwork once your payments cross reporting thresholds — worth remembering at tax time.
The part we will not soft-pedal
Before you chase any of the numbers above, know these five things:
- The risk is real. Investigational treatments can cause side effects, and in early-phase studies those effects are the least understood. Read every trial's risk disclosure as if it applies to you — because it might.
- Informed consent is your protection. Before you enroll, you receive an informed-consent document listing the study's purpose, procedures, risks, and compensation schedule. Read it fully, take it home, and ask every question you have before signing anything.
- You can withdraw at any time. Participation is voluntary from start to finish. You can leave a study at any point, for any reason, and keep the compensation you have already earned.
- Talk to your own doctor. We surface opportunities; we do not give medical advice. Whether a specific trial makes sense for your body and health history is a decision for you and your physician.
- Most applicants do not qualify for a given trial. Eligibility criteria are strict by design. Expect screening, and expect some rejections — that is normal, not a scam signal.
See what is actually recruiting right now
We do not list specific trials in articles, because enrollment changes weekly and stale listings waste your time. To see what is genuinely open:
- Browse our live directory of paid studies, or
- Answer a few questions and get matched to trials you may be eligible for:
See which trials you may qualify for →
Screening will filter you out of some studies. That is the system working as designed — and it is also why the people who do qualify are compensated fairly for their time.